Feb 23 Obalon Therapeutics Inc:
* Obalon Therapeutics Inc announces fourth quarter and full year 2016 financial results
* Q4 loss per share $0.51
* Q4 revenue $800,000 versus I/B/E/S view $697,000
* Q4 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
EU antitrust chief to speak at 1000 GMT on competition case
BRUSSELS, June 27 European Competition Commissioner Margrethe Vestager will hold a news conference on a competition case at 1200 CET (10 GMT), the European Commission said on Tuesday, with sources saying she would announce her verdict on a case concerning Alphabet's Google.